Chosa Oncology AB (W5L) Stock Price & News

All values in SEK	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	-	-3.93M	-	-
Cost of goods sold	-	-	-	-
Cost of revenue	-	-	-	-
Research and development expenses	-	-	-	-
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	2.48M	4.07M	1.96M	2.84M
Operating expense	2.49M	794.00K	1.96M	2.84M
Total operating expenses	2.49M	794.00K	1.96M	2.84M
Operating income	-2.49M	-4.72M	-1.96M	-2.84M
Other non operating income	-52.00K	-8.75K	-2.00K	1.00K
EBT including unusual items	-2.54M	-4.92M	-1.87M	-2.63M
EBT excluding unusual items	-2.54M	-4.92M	-1.87M	-2.63M
Income tax expense	-	-1.01M	-	-
Effective tax rate	-	20.60%	-	-
Other operating expenses	5.00K	-3.93M	-2.00K	1.00K
Net income	-2.54M	-3.91M	-1.87M	-2.63M
Net profit margin	-	99.41%	-	-
Earnings per share	-	-	-	-
Interest and investment income	-	310.20K	95.00K	248.00K
Interest expense	-	-116.05K	-2.00K	-43.00K
Net interest expenses	-	194.16K	93.00K	205.00K
Depreciation and amortization charges	-	-	-	-
EBITDA	-2.46M	-4.08M	-1.78M	-2.66M
Gain or loss from assets sale	-	-	-	-

Finance